# DNA X, Inc. (SONM) — capital_raise [announced]
Source: SEC API (secapi.ai) · situation sit_a96d8c0ae589d884b7d9 · retrieved 2026-08-11T16:15:11.160Z

## Overview
Overview We are a provider of crypto trading services to the public.

On July 8, 2026, DNA X, Inc. sold and issued 929,864 shares of Series B Preferred Stock in exchange for $2.5 million in cash proceeds and the cancellation of $3.1 million of outstanding convertible promissory note balance. The company expects to consummate the sale of the remaining 416,667 shares subscribed under the Purchase Agreement on or prior to August 14, 2026.

## Terms
- Consideration: mixed

## Key dates
- Announced 2026-07-09 · Expected close 2026-08-14

## Timeline
- 2026-07-09 · 8-K/A (0001493152-26-032680): 8-K/A - DNA X, Inc. — On July 8, 2026, DNA X, Inc. sold and issued 929,864 shares of Series B Preferred Stock in exchange for $2.5 million in cash proceeds and the cancellation of $3.1 million of outstanding convertible promissory note balance. The company expects to consummate the sale of the remaining 416,667 shares subscribed under the Purchase Agreement on or prior to August 14, 2026.
  https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-032680.txt

## Citations
- 0001493152-26-032680 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226032680